Lanean...

Interaction Potential of the Multitargeted Receptor Tyrosine Kinase Inhibitor Dovitinib with Drug Transporters and Drug Metabolising Enzymes Assessed in Vitro

Dovitinib (TKI-258) is under development for the treatment of diverse cancer entities. No published information on its pharmacokinetic drug interaction potential is available. Thus, we assessed its interaction with important drug metabolising enzymes and drug transporters and its efficacy in multidr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pharmaceutics
Egile Nagusiak: Weiss, Johanna, Theile, Dirk, Dvorak, Zdenek, Haefeli, Walter Emil
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2014
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4279137/
https://ncbi.nlm.nih.gov/pubmed/25521244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics6040632
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!